Clemmons; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clemmons; David.The latest application filed is for "heparin-binding domain of igfbp-2 in the treatment of metabolic disorders".

Company Profile

3.4.8

Clemmons; David - Chapel Hill NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders Grant 11,192,932 - Delale , et al. December 7, 2	2021-12-07
Heparin-binding Domain Of Igfbp-2 In The Treatment Of Metabolic Disorders App 20210196789 - DELALE; Thomas ; et al.	2021-07-01
Compounds, compositions and uses thereof for improvement of bone disorders Grant 10,947,285 - Clemmons , et al. March 16, 2	2021-03-16
Heparin-binding Domain Of Igfbp-2 In The Treatment Of Metabolic Disorders App 20190359676 - DELALE; Thomas ; et al.	2019-11-28
Compounds, Compositions And Uses Thereof For Improvement Of Bone Disorders App 20190352358 - CLEMMONS; David ; et al.	2019-11-21
Compounds, Compositions And Uses Thereof For Improvement Of Bone Disorders App 20180230191 - Clemmons; David ; et al.	2018-08-16
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1) App 20180016340 - CLEMMONS; David ; et al.	2018-01-18
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Grant 9,587,024 - Clemmons , et al. March 7, 2	2017-03-07
Compounds And Methods For Treating Obesity And Controlling Weight App 20160039897 - Clemmons; David	2016-02-11
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor I (IGF-1) App 20150259422 - CLEMMONS; David ; et al.	2015-09-17
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Grant 9,073,996 - Clemmons , et al. July 7, 2	2015-07-07
Monoclonal Antibodies For Enhancing Or Inhibiting Insulin-like Growth Factor 1 (igf-1) App 20140072568 - Clemmons; David ; et al.	2014-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.